BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23341714)

  • 1. Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.
    Lee SH; Kim KH; Lee SG; Chen DH; Jung DS; Moon CS; Park JY; Chung JS; Kwak IS; Cho GJ
    J Korean Med Sci; 2013 Jan; 28(1):67-73. PubMed ID: 23341714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
    Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
    HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of Cause of Death among Human Immunodeficiency Virus Patients and the Impact of Low CD4 Counts on Diagnosis to Death: a Retrospective Cohort Study.
    Kim Y; Kim SW; Chang HH; Kwon KT; Bae S; Hwang S
    J Korean Med Sci; 2020 Oct; 35(41):e355. PubMed ID: 33107229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries.
    Llibre JM; Revollo B; Vanegas S; Lopez-Nuñez JJ; Ornelas A; Marin JM; Santos JR; Marte P; Morera M; Zuluaga P; Tor J; Clotet B
    Scand J Infect Dis; 2013 Aug; 45(8):635-44. PubMed ID: 23547568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
    Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
    Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city: a persistent and deadly opportunistic infection.
    Tellez I; Barragán M; Franco-Paredes C; Petraro P; Nelson K; Del Rio C
    Am J Med Sci; 2008 Mar; 335(3):192-7. PubMed ID: 18344692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.
    Crum NF; Riffenburgh RH; Wegner S; Agan BK; Tasker SA; Spooner KM; Armstrong AW; Fraser S; Wallace MR;
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):194-200. PubMed ID: 16394852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India.
    Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Yephthomi T; Pradeep A; Saghayam S; Flanigan T; Mayer KH; Solomon S
    Int J Infect Dis; 2010 Feb; 14(2):e127-31. PubMed ID: 19632872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
    Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.
    Chow A; Tey J; Win MK; Leo YS
    Ann Acad Med Singap; 2012 Dec; 41(12):563-70. PubMed ID: 23303113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
    Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
    Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.
    Lewden C; Salmon D; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
    Int J Epidemiol; 2005 Feb; 34(1):121-30. PubMed ID: 15561752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.
    Radhi S; Alexander T; Ukwu M; Saleh S; Morris A
    BMC Infect Dis; 2008 Sep; 8():118. PubMed ID: 18796158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
    Mzileni MO; Longo-Mbenza B; Chephe TJ
    Pol Arch Med Wewn; 2008 Oct; 118(10):548-54. PubMed ID: 19112815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.
    Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
    Am J Epidemiol; 2013 Jan; 177(2):116-25. PubMed ID: 23287403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.